No abstract available
Publication types
-
Case Reports
-
Comment
-
Letter
MeSH terms
-
Angiogenesis Inhibitors / therapeutic use*
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Humanized
-
Bevacizumab
-
Humans
-
Male
-
Middle Aged
-
Telangiectasia, Hereditary Hemorrhagic / drug therapy*
-
Vascular Endothelial Growth Factor A / immunology
Substances
-
Angiogenesis Inhibitors
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Vascular Endothelial Growth Factor A
-
Bevacizumab